AI-generated summary
The authors studied a novel low-level light therapy for digital ulcers in systemic sclerosis, using a custom device with infrared, red and violet LEDs in 8 patients with 14 ulcers. The authors report no safety concerns, good patient-rated feasibility and tolerability, and improvements in ulcer assessment scores and blood flow over the study. Efficacy was assessed only tentatively.
- Participants
- 8
- Who or what was studied
- Eight patients with systemic sclerosis and 14 digital ulcers
- Wavelengths
- 850, 660, 405 nm
- Limits stated in the abstract
- The abstract describes a small feasibility study with tentative efficacy assessment and no comparison group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Locally acting, well-tolerated treatments for systemic sclerosis (SSc) digital ulcers (DUs) are needed.
Objectives
Our primary aim was to investigate the safety, feasibility, and tolerability of a novel low-level light therapy (LTTT). A secondary aim was to tentatively assess efficacy.
Methods
A custom-built device comprising infrared (850 nm), red (660 nm), and violet (405 nm) LEDs was utilized. DUs were irradiated with 10 J/cm2 twice weekly for 3 weeks, with follow-up at weeks 4 and 8. Any safety concerns were documented. Patient opinion on time to deliver, feasibility, and pain visual analogue score (VAS; 0-100, 100 most severe) was collected. Patient and clinician DU global assessment VAS were documented. DUs were evaluated by laser Doppler perfusion imaging pre- and post-irradiation.
Results
In all, 14 DUs in eight patients received a total of 46 light exposures, with no safety concerns. All patients considered LTTT 'took just the right amount of time' and was 'feasible', with a low associated mean pain VAS of 1.6 (SD: 5.2). Patient and clinician global DC VAS improved during the study (mean change: -7.1 and -5.2, respectively, both p < .001). DU perfusion significantly increased post-irradiation.
Conclusions
LTTT for DUs is safe, feasible, and well tolerated. There was an early tentative suggestion of treatment efficacy.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 850 nm, 660 nm, 405 nm
- Energy density (fluence)
- 10 J/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Visual analogue scale, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.